Transforming growth factor β1 (TGF-β1) in patients with endocrine ophthalmopathy and Graves’ disease: A predictor of treatment efficiency

Current therapeutic approaches to the treatment of endocrine ophthalmopathy (EOP) are based on nonspecific immunosuppression with glucocorticosteroids (GCs) and radiation therapy of the eye orbits. However, some patients exhibit resistance to the treatment. In a previous study, we have detected high...

Descrizione completa

Dettagli Bibliografici

Autori principali:	N. Yu. Sviridenko, E. G. Bessmertnaya, I. M. Belovalova, M. S. Sheremeta, D. M. Babaeva, N. M. Malysheva, E. A. Troshina, G. A. Melnichenko
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2022-11-01
Serie:	Медицинская иммунология
Soggetti:	graves’ disease endocrine ophthalmopathy cytokines antibodies glucocorticoids
Accesso online:	https://www.mimmun.ru/mimmun/article/view/2514
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!